Escolar Documentos
Profissional Documentos
Cultura Documentos
www.MansFans.com
Epidemiology
www.MansFans.com
Multiple Myeloma
• Malignancy of plasma cells
•Plasma cells >10% of bone marrow
Hallmarks
• Presence of monoclonal protein
• Anemia
• Renal failure
• Bone destruction (lytic bone lesions)
• Hypercalcemia
• Increased risk of infection
www.MansFans.com
Multiple Myeloma
Clinical Picture
Paraprotein
TRIAD
M o n o c lo n a l M a rro w Im m u n e
P r o te in In filtr a tio n D e fic ie n c y
LL 6
Bone
D e s tr u c tio n
Bone H y p e r c a lc a e m ia
P a in s
Symptoms
Bone pain
Tumor release of IL-6 (osteoclast
activating factor), causing lytic bone lesions
Infection
due to low Antibody production
Renal failure
Commonly due to hypercalcemia, Bence
Jones protein tubular damage, recurrent
pyelonephritis
www.MansFans.com
Symptoms
Normocytic normochromic anemia
Confusion
www.MansFans.com
Multiple Myeloma: Lab investigation
Immunofixation or immunoelectrophoresis:
of RBCs).
In uninvolved immunoglobulins.
+BJP in 24 hr urine collection (monoclonal light
chains). www.MansFans.com
Multiple Myeloma
BM PICTURE:
(Aspirate & Trephine Biopsy)
RADIODIAGNOSIS:
Radiological survey of the entire skeleton:
is mandatory.
MRI: is superior to CT for screening the vertebral column for
osteolytic lesions.
Bone scan: is not indicated (cold lesions).
REMEMBER!!
Iodine-containing contrast media may cause acute renal failure in
case of paraproteinaemia.
Lateral skull x-ray with typical findings of MM
Typical lesion in a tibia
Multiple Myeloma
•Major Criteria:
(1) Plasmacytoma on tissue biopsy
(2) Marrow plasmacytosis > 30 %.
(3) Monoclonal protein:
Ig G > 3.5 g / dl.
Ig A > 2 g / dl.
BJP > 1 g / 24 hr.
Multiple Myeloma
Minor Criteria:
(1) Marrow plasmacytosis 10-29 %.
(2) Monoclonal protein present but
less than the above levels
(3) Lytic bone lesions
(4) Decrease in uninvolved Ig:
Ig M < 50 mg / dl.
Ig A < 100 mg / dl.
Ig G < 600 mg / dl.
www.MansFans.com
Multiple Myeloma
Prognostic Factors
(1) Staging
(2) β-2 microglobulin
(3) CRP
(4) Cytogenetics
(5) LDH
www.MansFans.com
Treatment of MM
Criteria of Response:
CR:
•No M-band in serum or urine on electrophoresis.
•BJP < 200 mg/24 hrs
•Plasma cells in BM < 5%
VG PR:
•Decrease of M-band or light chains > 90 %.
•Plasma cells in BM < 10%
Treatment of MM
Criteria of Response:
PR:
Decrease of M-band or light chains in
urine > 50 %.
Minimal Response (MR):
Decrease of M-band or light chains in
urine > 25 %.
No Change (NC):
No change in any parameter.
Treatment of MM
Criteria of Response:
Progressive Disease(PD):
• Increase in M-band or light chains in
urine > 25 %.
• Development of new osteolytic
lesions.
• Newly developed hypercalcaemia.
Primary Resistance:
Response rate < 25 % after at least 4
full-dose treatment cycles.
Multiple Myeloma
A s y m p to m a tic S y m p to m a tic o r P D
N o tre a tm e n t M P till C R o r
M ax. R esponse
P r o g r e s s io n < 6 m o n th s P r o g r e s s io n > 6 m o n th s
VAD R epeat M P
PD PD
2 n d lin e VAD
T R E A T M E N T P L A N IN M M
P a tie n ts < 6 0 y r s o f A g e
3 c o u rs e s o f V A D
C R PR
H L A -T y p in g A n o th e r
3 c o u rs e s o f V A D
N o H L A - Id e n t ic a l H L A - Id e n t ic a l C R
S ib lin g S ib lin g
AB M T M in i-T r a n s p la n t
TREATM ENT PLAN
IN M M
P a tie n ts w ith M in im a l R e s p o n s e
First line:
MP •Melphalan 8 mg/m2 P.O. day 1-4
(0.25mg\Kg\day X 4 days)
•Prednisone 60 mg/m2 P.O. day 1-4
Repeat every 4 weeks
VAD •VCR 0.4 mg C.I. day 1-4
•Adriamycin 9 mg/ m2 C.I. day 1-4
•Dexamethasone 40 mg P.O. day 1-4 & 9-12
(& day 17-20 in cycle 1 only)
Repeat every 3 weeks
Chemotherapy of MM
Second line:
High dose dexamethasone:
40 mg I.V. day 1-4, 9-12,19-21.
DCEP •Dexamethasone 40 mg I.V. day 1-4
•Cyclophosphamide 300 mg/ m2 C.I. day 1-4
•Etoposide 30 mg/ m2 C.I. day 1-4
•Platinol 15 mg/ m2 C.I. day 1-4
CEP to be mixed together in 1L normal saline.
Not compatible with Mg or Kcl
Treatment of MM
Radiotherapy:
Indications:
• Big osteolytic lesions.
• Significant osteolytic lesions in
weight-bearing bone (for fear
of pathological fracture).
• Cord compression.
• Extramedullary plasmacytoma.